Initial functional disability as a 1-year prognostic factor in geriatric patients hospitalized with SARS-CoV-2 infection

Author:

Brière OlivierORCID,Otekpo Marie,Asfar Marine,Gautier Jennifer,Sacco GuillaumeORCID,Annweiler Cédric,

Abstract

Background SARS-CoV2 infection has affected many older people and has required us to adapt our practices to this new pathology. Initial functional capacity is already considered an important prognostic marker in older patients particularly during infections. Aim The objective of this longitudinal study was to determine whether baseline functional disability was associated with mortality risk after 1 year in older patients hospitalized for COVID-19. Methods All COVID-19 patients admitted to the geriatric acute care unit of Angers University Hospital, France, between March-June 2020 received a group iso-ressource (GIR) assessment upon admission. Disability was defined as a GIR score3. All-cause mortality was collected after 1 year of follow-up. Covariables were age, sex, history of malignancies, hypertension, cardiomyopathy, number of acute diseases at baseline, and use of antibiotics or respiratory treatments during COVID-19 acute phase. Results In total, 97 participants (mean±SD 88.0+5.4 years; 49.5% women; 46.4% GIR score≤3) were included. 24 of the 36 patients who did not survive 1 year had a GIR score ≤ 3 (66.7%; P = 0.003). GIR score≤3 was directly associated with 1-year mortality (fully adjusted HR = 2.27 95% CI: 1.07–4.89). Those with GIR3 at baseline had shorter survival time than the others (log-rank P = 0.0029). Conclusions Initial functional disability was associated with poorer survival in hospitalized frail elderly COVID-19 patients. Clinical trial registration ClinicalTrials.gov: NCT04560608 registered on September 23, 2022

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. WHO Coronavirus (COVID-19) Dashboard. [cited 31 Jan 2022]. Available: https://covid19.who.int

2. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. [cited 16 Jan 2021]. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention;Z Wu;JAMA,2020

4. A Geroscience Perspective on COVID-19 Mortality;DEL Promislow;J Gerontol A Biol Sci Med Sci,2020

5. Coronavirus: chiffres clés et évolution de la COVID-19 en France et dans le Monde. [cited 31 Jan 2022]. Available: https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3